IBIO
iBio, Inc.
1.10$
+1.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -48.8% | -58.4% | +12.7% | +354.5% | -18.8% | +44.7% | -20.5% | -97.3% | +350.0% | +77.8% | -75.0% | |
| – | +21.4% | +31.2% | -0.2% | – | – | +108.0% | +159.3% | -70.8% | +13.0% | – | – | |
| – | -48.8% | -58.4% | +12.7% | +354.5% | -53.7% | -2.8% | -309.8% | – | +350.0% | +77.8% | -75.0% | |
| – | -9.7% | +30.4% | -3.2% | +37.3% | -34.7% | +179.6% | -1.6% | +5.1% | -49.8% | +60.3% | +136.3% | |
| – | +53.0% | +37.3% | +1.3% | +15.4% | -7.8% | +90.9% | +0.3% | -12.6% | -38.6% | -8.4% | -0.9% | |
| – | +27.3% | +35.3% | +0.0% | +21.4% | -16.1% | +114.4% | -13.2% | +5.6% | -42.5% | +12.7% | +85.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +139.0% | -0.7% | -0.8% | +29.8% | -0.5% | -42.5% | -94.1% | +107.2% | +23.3% | -75.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -90.2% | -111.8% | – | -98.1% | +1,423.9% | -271.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.